XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L
Published in British journal of cancer (28.06.2011)
Published in British journal of cancer (28.06.2011)
Get full text
Journal Article
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
Buzdar, A.U., Xu, B., Digumarti, R., Goedhals, L., Hu, X., Semiglazov, V., Cheporov, S., Gotovkin, E., Hoersch, S., Rittweger, K., Miles, D.W., O’Shaughnessy, J., Tjulandin, S.
Published in Annals of oncology (01.03.2012)
Published in Annals of oncology (01.03.2012)
Get full text
Journal Article
Phase I Trial of 40-kd Branched Pegylated Interferon Alfa-2a for Patients With Advanced Renal Cell Carcinoma
MOTZER, Robert J, RAKHIT, Ashok, GINSBERG, Michelle, RITTWEGER, Karen, VUKY, Jacqueline, YU, Richard, FETTNER, Scott, HOOFTMAN, Leon
Published in Journal of clinical oncology (01.03.2001)
Published in Journal of clinical oncology (01.03.2001)
Get full text
Journal Article
Phase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma
Motzer, R. J., Rakhit, A., Thompson, J., Gurney, H., Selby, P., Figlin, R., Negrier, S., Ernst, S., Siebels, M., Ginsberg, M., Rittweger, K., Hooftman, L.
Published in Annals of oncology (01.11.2002)
Published in Annals of oncology (01.11.2002)
Get full text
Journal Article
5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)
Haller, D, Tabernero, J, Maroun, J, de Braud, F, Price, T, Van Cutsem, E, Hill, M, Gilberg, F, Rittweger, K, Schmoll, H
Published in European journal of cancer supplements (01.09.2009)
Published in European journal of cancer supplements (01.09.2009)
Get full text
Journal Article
A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study of Onartuzumab (METMAB) with Either Bevacizumab + Platinum + Paclitaxel or Pemetrexed + Platinum as First-Line Treatment for Patients (PTS) with Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Get full text
Journal Article
550P - TP, TS AND DPD as Potential Predictors of Outcome Following Capecitabine Plus Oxaliplatin (XELOX) vs. Bolus 5-Fluorouracil/Leucovorin (5-FU/LV) as Adjuvant Therapy for Stage III Colon Cancer: Updated Biomarker Findings from Study NO16968 (XELOXA)
Schmoll, H., Tabernero, J., Maroun, J.A., De Braud, F., Price, T., Van Cutsem, E., Hill, M., Hoersch, S., Rittweger, K., Haller, D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
TP, TS AND DPD as Potential Predictors of Outcome Following Capecitabine Plus Oxaliplatin (XELOX) vs. Bolus 5-Fluorouracil/Leucovorin (5-FU/LV) as Adjuvant Therapy for Stage III Colon Cancer: Updated Biomarker Findings from Study NO16968 (XELOXA)
Schmoll, H., Tabernero, J., Maroun, J.A., De Braud, F., Price, T., Van Cutsem, E., Hill, M., Hoersch, S., Rittweger, K., Haller, D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Abstract P6-11-02: Final Analysis of NO16853, a Randomized Phase II Non-Inferiority Study of Two Different Doses of Capecitabine in Combination with Docetaxel for Locally Advanced/Metastatic Breast Cancer (LA/MBC)
Buzdar, A, Tjulandin, S, Xu, B, Digumarti, R, Goedhals, L, Hu, X, Semiglazov, V, Cheporov, S, Gotovkin, E, Gilberg, F, Rittweger, K, Schaedeli Stark, F.
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Get full text
Journal Article
Microbial 7α-Hydroxylation of 3-Ketobisnorcholenol
DESPREAUX, C. W, RITTWEGER, K. R, PALLERONI, N. J
Published in Applied and Environmental Microbiology (01.05.1986)
Published in Applied and Environmental Microbiology (01.05.1986)
Get full text
Journal Article
Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia
Talpaz, Moshe, Rakhit, Ashok, Rittweger, Karen, O'Brien, Susan, Cortes, Jorge, Fettner, Scott, Hooftman, Leon, Kantarjian, Hagop
Published in Clinical cancer research (01.09.2005)
Published in Clinical cancer research (01.09.2005)
Get full text
Journal Article
Phase I Evaluation of a 40-kDa Branched-Chain Long-Acting Pegylated IFN-α-2a With and Without Cytarabine in Patients with Chronic Myelogenous Leukemia
Talpaz, Moshe, Rakhit, Ashok, Rittweger, Karen, O'Brien, Susan, Cortes, Jorge, Fettner, Scott, Hooftman, Leon, Kantarjian, Hagop
Published in Clinical cancer research (01.09.2005)
Published in Clinical cancer research (01.09.2005)
Get full text
Journal Article
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B
Carreño, Vicente, Zeuzem, Stefan, Hopf, Uwe, Marcellin, Patrick, Cooksley, W.Graham E., Fevery, Johan, Diago, Moisés, Reddy, Rajender, Peters, Marion, Rittweger, Karen, Rakhit, Ashok, Pardo, Margarita
Published in Journal of hepatology (01.02.2000)
Published in Journal of hepatology (01.02.2000)
Get full text
Journal Article
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma
Motzer, R J, Rakhit, A, Thompson, J, Gurney, H, Selby, P, Figlin, R, Negrier, S, Ernst, S, Siebels, M, Ginsberg, M, Rittweger, K, Hooftman, L
Published in Annals of oncology (01.11.2002)
Published in Annals of oncology (01.11.2002)
Get full text
Journal Article
Pharmacokinetic (PK) interactions between capecitabine (X), oxaliplatin (O) and bevacizumab (A) when used in combination for first-line treatment of metastatic colorectal cancer (MCRC)
Brennan, B., Siu, L., Dhesy-Thind, B., Cripps, C., Gandhi, A., Abt, M., Smith, K., Rittweger, K., Hussain, S., Choudhury, S.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
Buzdar, A U, Xu, B, Digumarti, R, Goedhals, L, Hu, X, Semiglazov, V, Cheporov, S, Gotovkin, E, Hoersch, S, Rittweger, K, Miles, D W, O'Shaughnessy, J, Tjulandin, S
Published in Annals of oncology (01.03.2012)
Get full text
Published in Annals of oncology (01.03.2012)
Journal Article
A phase I/II study of recombinant human interleukin‐12 in patients with chronic hepatitis C
Zeuzem, Stefan, Hopf, Uwe, Carreno, Vicente, Diago, Moisés, Shiffman, Mitchell, Grüne, Stefan, Dudley, Francis J., Rakhit, Ashok, Rittweger, Karen, Yap, Sing Hiem, Koff, Raymond S., Thomas, Howard C.
Published in Hepatology (Baltimore, Md.) (01.04.1999)
Published in Hepatology (Baltimore, Md.) (01.04.1999)
Get full text
Journal Article
Microbial 7alpha-hydroxylation of 3-ketobisnorcholenol
Despreaux, C W, Rittweger, K R, Palleroni, N J
Published in Applied and environmental microbiology (01.05.1986)
Get full text
Published in Applied and environmental microbiology (01.05.1986)
Journal Article